QuidelOrtho Corporation — Form 8-K Summary
Business Context and Reporting Period
QuidelOrtho Corporation filed this Form 8-K to report the final voting results from its 2024 Annual Meeting of Stockholders, held on May 14, 2024. The report was signed and filed on May 17, 2024. The filing does not report operating or financial results for a quarterly or annual reporting period.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating performance metrics.
Material Changes Versus the Prior Comparable Period
No comparable-period financial or operating information is included. The filing reports only annual meeting voting outcomes.
Governance, Outlook, Risks, and Unusual Items
- Stockholders elected all ten nominees to the Board of Directors: Kenneth F. Buechler, Evelyn S. Dilsaver, Edward L. Michael, Mary Lake Polan, James R. Prutow, Ann D. Rhoads, Robert R. Schmidt, Matthew W. Strobeck, Kenneth J. Widder, and Joseph D. Wilkins Jr.
- Stockholders approved, on an advisory basis, the compensation of the named executive officers: 54,888,387 votes for, 3,194,023 against, 879,159 abstentions, and 4,262,897 broker non-votes.
- Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2024: 61,334,670 votes for, 1,022,808 against, and 866,988 abstentions.
- The filing does not provide management guidance, outlook commentary, risk updates, contingencies, or unusual financial items.
Key Facts for Investors to Verify
- Confirm the composition and continued service of the ten directors elected at the annual meeting.
- Review the proxy statement filed April 2, 2024 for director qualifications, executive compensation details, and proposal disclosures.
- Confirm Ernst & Young LLP’s appointment as the auditor for fiscal year 2024.
- Review separate periodic filings for QuidelOrtho’s financial results, liquidity, debt, guidance, and risk factors, which are not addressed in this Form 8-K.